Physiological SCFAs may confer indirect anti-synuclein benefit through an enteroendocrine FFAR2/FFAR3 to GLP-1 axis

Score evolution starts here

This hypothesis hasn't been debated, funded, or backed by evidence yet. Be the first to push the science loop forward.

Open a debate → Open a market